Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Patterson Companies stock in Canada | $32.54
Own Patterson Companies shares in just a few minutes.
Patterson Companies is a medical distribution business based in the US. Patterson Companies stocks (PDCO.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $29.92 – a decrease of 2.72% over the previous week. Patterson Companies employs 7,800 staff and has a trailing 12-month revenue of around $5.9 billion.
How to buy Patterson Companies stock in Canada
- Choose a platform. If you're a beginner, our stock trading table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: PDCO in this case.
- Research Patterson Companies stocks. The platform should provide the latest information available.
- Buy your Patterson Companies stocks. It's that simple.
What's in this guide?
- Can I buy shares in Patterson Companies?
- Has coronavirus impacted Patterson Companies shares?
- Patterson Companies shares summary
- Compare share dealing platforms
- Is Patterson Companies stock a buy or sell?
- Patterson Companies performance over time
- Can I short Patterson Companies shares?
- Are Patterson Companies shares over-valued?
- Patterson Companies's financials
- How volatile are Patterson Companies shares?
- Does Patterson Companies pay a dividend?
- Have Patterson Companies shares ever split?
- Other common questions
How has Coronavirus impacted Patterson Companies's stock price?
Since the stock market crash in March caused by coronavirus, Patterson Companies's stock price has had significant positive movement.
Its last market close was $32.54, which is 30.15% up on its pre-crash value of $22.73 and 151.27% up on the lowest point reached during the March crash when the stocks fell as low as $12.95.
If you had bought $1,000 worth of Patterson Companies stocks at the start of February 2020, those stocks would have been worth $724.66 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,456.49.
Patterson Companies stock priceUse our graph to track the performance of PDCO stocks over time.
Patterson Companies stocks at a glance
|Latest market close||$32.54|
|52-week range||$21.5872 - $37.37|
|50-day moving average||$32.3477|
|200-day moving average||$32.5617|
|Wall St. target price||$33.58|
|Dividend yield||$1.04 (3.44%)|
|Earnings per share (TTM)||$1.61|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Patterson Companies stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Patterson Companies price performance over time
|1 month (2021-06-28)||6.90%|
|3 months (2021-04-28)||-0.58%|
Is Patterson Companies under- or over-valued?
Valuing Patterson Companies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Patterson Companies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Patterson Companies's P/E ratio
Patterson Companies's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 19x. In other words, Patterson Companies stocks trade at around 19x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the stocks or simply that they're under-valued.
Patterson Companies's PEG ratio
Patterson Companies's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0182. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Patterson Companies's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.
Patterson Companies's EBITDA
Patterson Companies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$292.8 million.
The EBITDA is a measure of a Patterson Companies's overall financial performance and is widely used to measure a its profitability.
Patterson Companies financials
|Revenue TTM||USD$5.9 billion|
|Operating margin TTM||3.62%|
|Gross profit TTM||USD$1.2 billion|
|Return on assets TTM||4.89%|
|Return on equity TTM||17.22%|
|Market capitalisation||USD$2.9 billion|
TTM: trailing 12 months
How to short and sell Patterson Companies stocks
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "PDCO.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 7.4 million Patterson Companies stocks held short by investors – that's known as Patterson Companies's "short interest". This figure is 4.9% down from 7.8 million last month.
There are a few different ways that this level of interest in shorting Patterson Companies stocks can be evaluated.
Patterson Companies's "short interest ratio" (SIR)
Patterson Companies's "short interest ratio" (SIR) is the quantity of Patterson Companies stocks currently shorted divided by the average quantity of Patterson Companies stocks traded daily (recently around 1.4 million). Patterson Companies's SIR currently stands at 5.14. In other words for every 100,000 Patterson Companies stocks traded daily on the market, roughly 5140 stocks are currently held short.
However Patterson Companies's short interest can also be evaluated against the total number of Patterson Companies stocks, or, against the total number of tradable Patterson Companies stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Patterson Companies's short interest could be expressed as 0.08% of the outstanding stocks (for every 100,000 Patterson Companies stocks in existence, roughly 80 stocks are currently held short) or 0.0858% of the tradable stocks (for every 100,000 tradable Patterson Companies stocks, roughly 86 stocks are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the stock price, with fewer people currently willing to bet against Patterson Companies.
Find out more about how you can short Patterson Companies stock.
Patterson Companies stock dividends
Dividend payout ratio: 54.17% of net profits
Recently Patterson Companies has paid out, on average, around 54.17% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.41% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Patterson Companies shareholders could enjoy a 3.41% return on their shares, in the form of dividend payments. In Patterson Companies's case, that would currently equate to about $1.04 per share.
Patterson Companies's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Patterson Companies's most recent dividend payout was on 6 August 2021. The latest dividend was paid out to all shareholders who bought their stocks by 22 July 2021 (the "ex-dividend date").
Have Patterson Companies stocks ever split?
Patterson Companies stocks were split on a 2:1 basis on 25 October 2004. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Patterson Companies stocks – just the quantity. However, indirectly, the new 50% lower stock price could have impacted the market appetite for Patterson Companies stocks which in turn could have impacted Patterson Companies's stock price.
Patterson Companies stock price volatility
Over the last 12 months, Patterson Companies's stocks have ranged in value from as little as $21.5872 up to $37.37. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Patterson Companies's is 1.5734. This would suggest that Patterson Companies's stocks are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Patterson Companies overview
Patterson Companies, Inc. distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada. It operates through three segments; Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritionals, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.
Stocks similar to Patterson Companies
Patterson Companies in the news
Why Is Patterson Cos. (PDCO) Down 4.3% Since Last Earnings Report?
First Week of September 17th Options Trading For Patterson Companies
Should I Buy Patterson Companies, Inc. (PDCO)?
Frequently asked questions
More guides on Finder
How to buy Zevia PBC (ZVIA) stock in Canada
Everything we know about the Zevia PBC IPO, plus information on how to buy in.
How to buy Xponential Fitness (XPOF) stock in Canada
Everything we know about the Xponential Fitness IPO, plus information on how to buy in.
How to buy SOPHiA Genetics (SOPH) stock in Canada
Everything we know about the SOPHiA Genetics IPO, plus information on how to buy in.
How to buy Ryan Specialty Group Holdings (RYAN) stock in Canada
Everything we know about the Ryan Specialty Group Holdings IPO, plus information on how to buy in.
How to buy Ocean Biomedical (OCEA) stock in Canada when it goes public
Everything we know about the Ocean Biomedical IPO, plus information on how to buy in.
How to buy Instructure Holdings (INST) stock in Canada
Everything we know about the Instructure Holdings IPO, plus information on how to buy in.
How to buy Gambling.com Group (GAMB) stock in Canada
Everything we know about the Gambling.com Group IPO, plus information on how to buy in.
How to buy Elicio Therapeutics (ELTX) stock in Canada when it goes public
Everything we know about the Elicio Therapeutics IPO, plus information on how to buy in.
How to buy Cytek Biosciences (CTKB) stock in Canada
Everything we know about the Cytek Biosciences IPO, plus information on how to buy in.
How to buy Core & Main (CNM) stock in Canada
Everything we know about the Core & Main IPO, plus information on how to buy in.